We further investigated the predictive role of ORM1 in CRLM by detecting ORM1 expression levels in 10 blood samples from patients with benign liver diseases (hepatic hemangioma and FNH) or malignant tumors (HCC and ICC) using ELISA. Here, ORM1 is linked to intrahepatic cholangiocarcinoma.